Hyperhomocysteinaemia and vascular injury: advances in mechanisms and drug targets.

Yi FuXian WangWei Kong

Published in: British journal of pharmacology (2017)

This article is part of a themed section on Spotlight on Small Molecules in Cardiovascular Diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.8/issuetoc.

Keyphrases

cardiovascular disease
benign prostatic hyperplasia
lower urinary tract symptoms
type diabetes
adverse drug
emergency department
metabolic syndrome
coronary artery disease